{
  "trial_id": "NCT02207660",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "stage IVB, recurrent or metastatic cervical cancer",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "treated with P-HDFL",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "recurrent cervical cancer undergoing salvage surgery and receiving P-HDFL as adjuvant therapy",
      "label": "triggers",
      "evidence": "none"
    }
  ],
  "notes": "Patient has stage IVB, recurrent or metastatic cervical cancer treated with P-HDFL. However, he is undergoing salvage surgery and receiving P-HDFL as adjuvant therapy, which triggers exclusion.",
  "_meta": {
    "topic_id": "54",
    "trial_id": "NCT02207660",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}